Peter Svennilson
CIK 1606074 · last filed 2023-01-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$158.34M
Companies
7
Total Filings
64
Lifetime Open-Market Net
-$56.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Director | 11,203,333 | $1.54 | $17.25M | $72.49M | 36 | 2023-01-17 |
| RAPT Therapeutics, Inc. (RAPT) Delisted | Director | 1,547,409 | $58.01 | $89.77M | -$43.47M | 7 | 2022-05-27 |
| ORIC | Director | 4,616,666 | $8.27 | $38.18M | $0 | 3 | 2021-06-17 |
| RVMD | Director | 705,313 | $153.87 | $108.53M | -$84.23M | 6 | 2021-04-28 |
| CONSTELLATION PHARMACEUTICALS INC (CNST) Delisted | Director | 2,604,528 | $33.99 | $88.53M | -$1.11M | 2 | 2021-02-19 |
| NRIX | 10%+ Owner | 686,274 | $16.95 | $11.63M | $0 | 1 | 2020-07-29 |
| Gritstone bio, Inc. (GRTS) Delisted | Director | 3,102,934 | $0.03 | $99.9K | $0 | 2 | 2019-06-20 |
Recent Filings · Page 3 of 7
64 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-27 | ORIC | Grant (A) | — | $0 | EDGAR |
| 2020-04-09 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +112,602 | $1.68M | EDGAR |
| 2020-04-07 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +138,315 | $1.96M | EDGAR |
| 2020-04-02 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +250,984 | $3.11M | EDGAR |
| 2020-03-25 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +301,180 | $3.58M | EDGAR |
| 2020-03-23 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +291,546 | $3.40M | EDGAR |
| 2020-03-06 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +8,307 | $149.5K | EDGAR |
| 2020-03-04 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +62,868 | $1.13M | EDGAR |
| 2020-02-28 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +75,447 | $1.35M | EDGAR |
| 2020-02-10 | NGM BIOPHARMACEUTICALS INC (NGM) Delisted | Buy (P) | +44,900 | $716.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.